ASIT Biotech S.A. | Mutual Funds
Mutual Funds that own ASIT Biotech S.A.
BNP Paribas B - Pension Balanced
78,847
0.46%
0
0.01%
09/29/2017
HSBC Micro Caps Euro
68,592
0.4%
0
0.4%
12/29/2017
57,146
0.33%
0
0.06%
07/31/2018
Metropolitan - Rentastro Growth
23,823
0.14%
0
0.01%
07/31/2018
21,250
0.12%
0
0.15%
06/30/2017
BNP Paribas B - Pension Growth
13,086
0.08%
0
0.01%
09/29/2017
MG Expansion France
10,000
0.06%
1,500
0.24%
12/29/2017
BNP Paribas B - Pension Stability
7,098
0.04%
0
0.01%
09/29/2017
1,750
0.01%
0
0.49%
09/29/2017
| Address |
Avenue Ariane 5
Woluwe-Saint-Lambert BU 1200
Belgium
|
|
Employees
|
- |
| Website |
http://www.asitbiotech.com |
| Updated |
07/08/2019 |
| ASIT BioTech SA operates as clinical stage biopharmaceutical company. It focuses on the development and future commercialization of immunotherapy products for the treatment of allergies, based on its ASIT technology platform. The company was founded by Thierry Legon in May 1997 and is headquartered in Brussels, Belgium. |
